7 Prostate Cancer Headlines You Can’t Miss


6. Prostate Cancer Blood Test, APIFINY, Being Promoted in US by Aeterna Zentaris

APIFINY blood test

Aeterna Zentaris Inc. announced it has begun promoting  APIFINY, the only non-PSA blood test for the evaluation of prostate cancer risk, in the U.S. under a co-marketing agreement with Armune BioScience, Inc. Under the agreement, Zentaris will promote APIFINY to designated medical professionals in 20 American territories, and receive a commission for each test that results from its promotion, the company says in its press release.

Read more about it: http://bit.ly/1SgD3Az

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published.